Furthermore, suppression of SOAT1 inhibits the proliferation and migration of HCC cells and the treatment with the SOAT1 inhibitor avasimibe reduced the size of tumors in patient-derived tumour xenograft mouse models [124]. The gene discussed is SOAT1; the disease is hepatocellular carcinoma.